ArticleCureus2026
Botulinum Toxin Type A-assisted Mesh-Free Endoscopic Repair of a Pediatric Ventral Hernia After Giant Omphalocele: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Residual ventral hernia after giant omphalocele presents a complex reconstructive challenge in pediatric surgery because of altered abdominal wall anatomy, muscular retraction, and the need to achieve closure without excessive tension. Botulinum toxin type A has been used as an adjunct to abdominal wall reconstruction by inducing temporary muscular relaxation, but pediatric experience remains limited, particularly in combination with endoscopic preaponeurotic repair (REPA). We report the case of a five-year-old boy weighing 13.4 kg with a residual ventral hernia after a giant omphalocele. Preoperative ultrasonography demonstrated a 6 cm fascial defect. The patient underwent ultrasound-guided botulinum toxin type A infiltration using 14 injection sites distributed bilaterally along the rectus abdominis and lateral abdominal wall musculature. A total dose of 70 IU was administered. Four weeks later, the defect diameter had decreased to 4 cm, and mesh-free REPA was performed. Complete musculoaponeurotic closure was achieved without prosthetic mesh, progressive preoperative pneumoperitoneum, or surgical component separation. The postoperative course was uneventful, and no clinical recurrence or wound-related complication was observed at 12 months of follow-up. This case describes a technically successful combination of preoperative botulinum toxin type A infiltration and mesh-free REPA in a child with a post-omphalocele ventral hernia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.